当前位置: 首页 > 期刊 > 《中国医学创新》 > 2014年第5期 > 正文
编号:12708010
氯沙坦与吲达帕胺联合钙离子拮抗剂治疗3级高血压伴左室肥厚的临床对照研究(3)
http://www.100md.com 2014年2月15日 李新玲
第1页

    参见附件。

     [2] Devereux R B,Pickering T G,Harshfield G A,et al.Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress[J].Circulation,1983,68(3):470-476.

    [3]杜晓军,李雷.吲哒帕胺治疗老年高血压临床观察[J].中国校医,2006,20(4):426-427.

    [4]郭冀珍,孙宁玲,吴宗贵,等.动态血压监测评价吲哒帕胺新型缓释片的降压作用[J].中华心血管病杂志,2002,30(7):393-396.

    [5] Johnson R J,Kang D H,Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?[J].Hypertension,2003,41(6):1183-1190.

    [6]何森,陈晓平,蒋凌云,等.中老年人群血尿酸水平和早期肾功能损害的关系[J].中华医学杂志,2010,90(10):658-661.

    [7] Lonn E,Shaikholeslami R,Yi Q,et al.Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction:a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial[J].J Am Coll Cardiol,2004,43(12):2200-2206.

    [8] Mattioli A V,Bonatti S,Monopoli D,et al.Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension[J].Blood Press,2005,14(5):273-278.

    [9]于海波,韩雅玲,高柏青,等.替米沙坦改善原发性高血压病患者心肌肥厚及早期肾功能失调[J].心脏杂志,2005,17(1):39-41.

    (收稿日期:2013-11-25) (本文编辑:蔡元元)

您现在查看是摘要介绍页,详见PDF附件